Key facts
- This page summarizes Column Group IV GP, LP's Form 3 filing for Eikon Therapeutics, Inc. (EIKN).
- 0 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 04 Feb 2026, 21:59.
Column Group IV GP, LP - 04 Feb 2026 Form 3 Insider Report for Eikon Therapeutics, Inc. (EIKN)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- EIKN
- Reported as of
- 04 Feb 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 04 Feb 2026, 21:59:07 UTC
- Next SEC filing
- 09 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- The Column Group IV, LP, by The Column Group IV GP, LP, its general partner, /s/ James Evangelista Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Column Group IV GP, LP filed Form 3 for Eikon Therapeutics, Inc. (EIKN) on 04 Feb 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (5)
CIK 0001796356
Primary reporting owner
Column Group IV GP, LP
- Relationship
- 10%+ Owner
- Address
- 1 LETTERMAN DRIVE, BUILDING D, SUITE DM-900, SAN FRANCISCO
- Signature
- The Column Group IV, LP, by The Column Group IV GP, LP, its general partner, /s/ James Evangelista Attorney-in-Fact
- Signature date
- 04 Feb 2026
CIK 0001796353
Column Group IV-A, LP
- Relationship
- 10%+ Owner
- Address
- 1 LETTERMAN DRIVE, BUILDING D, SUITE DM-900, SAN FRANCISCO
- Signature
- The Column Group IV-A, LP, by The Column Group IV GP, LP, its general partner, /s/ James Evangelista Attorney-in-Fact
- Signature date
- 04 Feb 2026
CIK 0001931825
Column Group Opportunity III, LP
- Relationship
- 10%+ Owner
- Address
- 1 LETTERMAN DRIVE, BUILDING D, SUITE DM-900, SAN FRANCISCO
- Signature
- The Column Group IV GP, LP, /s/ James Evangelista Attorney-in-Fact
- Signature date
- 04 Feb 2026
CIK 0001932874
Column Group Opportunity III GP, LP
- Relationship
- 10%+ Owner
- Address
- 1 LETTERMAN DRIVE, BUILDING D, SUITE DM-900, SAN FRANCISCO
- Signature
- The Column Group Opportunity III, LP, by The Column Group Opportunity GP, LP its general partner, by TCG Opportunity III GP, LLC, its general partner, /s/ James Evangelista Attorney-in-Fact
- Signature date
- 04 Feb 2026
CIK 0001932445
TCG Opportunity III GP, LLC
- Relationship
- 10%+ Owner
- Address
- 1 LETTERMAN DRIVE, BUILDING D, SUITE DM-900, SAN FRANCISCO
- Signature
- The Column Group Opportunity GP, LP, by TCG Opportunity III GP, LLC, its general partner, /s/ James Evangelista Attorney-in-Fact
- Signature date
- 04 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EIKN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 63,691
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Footnotes
- F1
EIKN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,352
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EIKN
holding
Derivative
Series A Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 1,296,629
- Exercise price
- Footnotes
- F1, F3
EIKN
holding
Derivative
Series A Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 44,249
- Exercise price
- Footnotes
- F2, F3
EIKN
holding
Derivative
Series A-1 Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 1,403,568
- Exercise price
- Footnotes
- F1, F4
EIKN
holding
Derivative
Series A-1 Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 47,898
- Exercise price
- Footnotes
- F2, F4
EIKN
holding
Derivative
Series C-1 Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 110,928
- Exercise price
- Footnotes
- F1, F5
EIKN
holding
Derivative
Series C-1 Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 3,785
- Exercise price
- Footnotes
- F2, F5
EIKN
holding
Derivative
Series D Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 688,283
- Exercise price
- Footnotes
- F6, F7
EIKN
holding
Derivative
Warrant
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Feb 2026
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 573,569
- Exercise price
- $43.59
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The shares are directly held by The Column Group IV, LP ("TCG IV LP"). The Column Group IV GP, LP ("TCG IV GP LP") is the general partner of TCG IV LP and may be deemed to have voting and investment power with respect to shares directly held by TCG IV LP. Peter Svennilson and Tim Kutzkey are the managing partners of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to securities directly held by TCG IV LP. Each of the Reporting Persons disclaims beneficial ownership of the securities noted herein, except to the extent of its or his pecuniary interest therein.
Footnote F2
The shares are directly held by The Column Group IV-A, LP ("TCG IV-A LP"). TCG IV GP LP is the general partner of the TCG IV-A LP and may be deemed to have voting and investment power with respect to shares directly held by the Reporting Person. Peter Svennilson and Tim Kutzkey are the managing partners of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to securities directly held by TCG IV-A LP. Each of the Reporting Persons disclaims beneficial ownership of the securities noted herein, except to the extent of its or his pecuniary interest therein.
Footnote F3
The Series A Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Immediately prior to the closing of the Issuer's initial public offering ("IPO"), all shares of Series A Preferred Stock will be converted into shares of Common Stock of the Issuer.
Footnote F4
The Series A-1 Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Immediately prior to the closing of the Issuer's IPO, all shares of Series A-1 Preferred Stock will be converted into shares of Common Stock of the Issuer.
Footnote F5
The Series C-1 Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Immediately prior to the closing of the Issuer's IPO, all shares of Series C-1 Preferred Stock will be converted into shares of Common Stock of the Issuer.
Footnote F6
The Series D Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Immediately prior to the closing of the Issuer's IPO, all shares of Series C-1 Preferred Stock will be converted into shares of Common Stock of the Issuer.
Footnote F7
The securities are directly held by The Column Group Opportunity III, LP ("TCG Opportunity III LP"). The Column Group Opportunity III GP, LP ("TCG Opportunity III GP LP") is the general partner of TCG Opportunity III LP. TCG Opportunity III GP, LLC is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP. Each of TCG Opportunity III GP LP and TCG Opportunity III GP, LLC may be deemed to have voting, investment and dispositive power with respect to securities directly held by TCG Opportunity III LP. Peter Svennilson and Tim Kutzkey are the managing members of TCG Opportunity III GP, LLC and may each be deemed to share voting, investment and dispositive power with respect to securities directly held by TCG Opportunity III LP. Each of the Reporting Persons disclaims beneficial ownership of the securities noted herein, except to the extent of its or his pecuniary interest therein.